762 results on '"Macular degeneration -- Reports"'
Search Results
252. Researchers from University of Miami, Bascom Palmer Eye Institute detail new studies and findings in the area of proteomics
253. Studies from National Eye Institute in the area of cholesterol described
254. Scientists at Second Military Medical University, Department of Ophthalmology discuss research in intercellular signaling peptides and proteins
255. Researchers at University of California, Jules Stein Eye Institute release new data on stargardt disease
256. Chapter 5 Global trends in functional foods by health concern
257. New Retinopathy Study Findings Have Been Reported by Researchers at Pomeranian Medical University (New insight into the role of the complement in the most common types of retinopathy-current literature review)
258. New Tumor Necrosis Factors Study Findings Recently Were Reported by N. Angayarkanni and Co-Researchers (Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNF alpha induced pro-angiogenic and ...)
259. Findings from University of Kiel Broaden Understanding of Clinical and Experimental Ophthalmology (Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies)
260. Researchers from National Center for Scientific Research (CNRS) Discuss Findings in Ophthalmology [Real study: Re-treatment evaluated on visual acuity for Lucentis [R] in neovascular AMD]
261. New Findings on Medical Research from J.P. Ansah and Co-Authors Summarized (Projection of Eye Disease Burden in Singapore)
262. Researchers from medignition Inc Report Findings in Age-Related Macular Degeneration (Accuracy of a Self-monitoring Test for Identification and Monitoring of Age-related Macular Degeneration: A Diagnostic Case-control Study)
263. Report from Europe
264. RNIB study: obesity doubles risk of AMD
265. Endothelial cells analysis after intravitreal ranibizumab (Lucentis) in age-related macular degeneration treatment: a pilot study
266. Ophthalmology Drug Development Pipeline Review, Market 2016 - Hexa Reports
267. Ophthalmology Drug Industry Development and Pipeline Review, 2016 | Market Research Report By Hexa Reports
268. Ophthalmology Drug Industry Development and Pipeline Review, 2016 | Market Research Report By Hexa Reports
269. AVEO, OPHT: Recommendations
270. Ophthalmology Drug Industry Development and Pipeline Review, 2016 | Market Research Report By Hexa Reports
271. Global Ophthalmology Therapeutics Frontier Pharma Market Research Report 2016: Ophthalmology's Diverse Pipeline Could Rejuvenate Previously Stagnant Therapy Area
272. Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026
273. Global Age-related Macular Degeneration Market Growth of 7.37% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Bayer Healthcare, Novartis, Alcon - Research and Markets
274. Age-Related Macular Degeneration - Market Trends and Forecasts: Technavio
275. Limits of the retinal-mapping program in age-related macular degeneration
276. Europe Age-related Macular Degeneration Market and Competitive Landscape Highlights Report 2016 - Research and Markets
277. Europe Age-related Macular Degeneration Market and Competitive Landscape Highlights Report 2016
278. Europe Age-related Macular Degeneration Market and Competitive Landscape Highlights Report 2016
279. DOCTORS' OF OPTOMETRY AMD ASSESSMENTS COMPARABLE TO OPHTHALMOLOGISTS
280. Retinal Diseases: Wet and Dry AMD, Diabetic Retinopathy Market 2016-2026: Aflibercept, Ranibizumab, Bevacizumab, Verteporfin, Ocriplasmin, Anti-VEGF, Anti-PDGF
281. Age Related Macular Degeneration Pipeline Landscape and Therapeutics Market 2016 Review
282. Global Age Related Macular Degeneration Therapeutics Report 2016 - Pipeline Review of 100+ Companies & Drug Profiles - Research and Markets
283. Global Age Related Macular Degeneration Therapeutics Report 2016 - Pipeline Review of 100+ Companies & Drug Profiles
284. Global Age Related Macular Degeneration Therapeutics Report 2016 - Pipeline Review of 100+ Companies & Drug Profiles
285. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis - Research and Markets
286. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis
287. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis
288. Guidance and hope for people living with the most-common age-related vision problem
289. Guidance and hope for people living with the most-common age-related vision problem
290. Guidance and hope for people living with the most-common age-related vision problem
291. Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials - Research and Markets
292. Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials
293. Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials
294. USC ROSKI EYE INSTITUTE PUBLISHES FIRST STUDY TO ANALYZE AMD RISK, PREVALENCE AND IMPACT ON QUALITY OF LIFE FOR OLDER LATINOS
295. Global Age-Related Macular Degeneration Partnering Deals and Agreements 2010-2016 - Access to Headline, Upfront, milestone and royalty data
296. Global Age-Related Macular Degeneration Partnering 2010 to 2016 - Research and Markets
297. Global Age-Related Macular Degeneration Partnering 2010 to 2016
298. Global Age-Related Macular Degeneration Partnering 2010 to 2016
299. Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026
300. Nearly 3 out of 4 Americans Don't Know the Leading Cause of Blindness in People Over Age 60
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.